Mubadala Investment Company’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-39,424
Closed -$4.74M – 91
2026
Q1
$4.74M Buy
+39,424
New +$4.55M 0.02% 31
2025
Q4
– Sell
-48,613
Closed -$4.08M – 84
2025
Q3
$4.08M Buy
48,613
+4,000
+9% +$329K 0.02% 25
2025
Q2
$3.53M Buy
+44,613
New +$3.55M 0.02% 31

Other funds holding MRK

Mubadala Investment Company's MRK Position: Q2 2026 in Review

Mubadala Investment Company sold out of Merck (MRK) in Q2 2026, closing a stake of 39,424 shares — an estimated $4.74M sold.

Mubadala Investment Company first reported a position in MRK in Q2 2025 and held it in 3 quarters. The position peaked at $4.74M in Q1 2026. 3,851 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mubadala Investment Company reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Mubadala Investment Company sold 39,424 Merck shares in Q2 2026, an estimated $4.74M.
  • Mubadala Investment Company first reported a position in Merck in Q2 2025 and held it in 3 quarters.
  • Mubadala Investment Company's Merck position peaked at $4.74M in Q1 2026.
  • 3,851 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mubadala Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.